Inflammatory processes In diet-Induced pancreatic cancer promotion
饮食诱发的胰腺癌促进中的炎症过程
基本信息
- 批准号:8373905
- 负责人:
- 金额:$ 20.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal FeedAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryCaloriesCell Culture SystemCellsChronic DiseaseDevelopmentDietDietary SupplementationDinoprostoneDiseaseDoseEconomicsEicosanoidsEngineeringEnvironmentFatty acid glycerol estersFish OilsGrowthGrowth and Development functionHealthHistologicIn VitroIncidenceInflammationInflammation MediatorsInflammatoryInflammatory InfiltrateInflammatory ResponseInstructionLesionMalignant NeoplasmsMalignant neoplasm of pancreasMediatingNon-MalignantObesityObesity associated cancerOilsOmega-3 Fatty AcidsOral AdministrationOutcomePancreasPancreatic AdenocarcinomaPancreatic Intraepithelial NeoplasiaPharmaceutical PreparationsPlayProcessProstaglandinsPublishingResearch PersonnelRoleSignal PathwaySocietiesStagingTestingTransgenic MiceXenograft procedurecancer preventiondietary supplementsfeedingmacrophagemouse modelpreventprogramsreceptortumor
项目摘要
There is substantial evidence that the Western-style diet, rich in fats and calories, is a critical factor in the
development of obesity and other chronic diseases, including cancer. Although the underlying mechanisms
are likely multi-faceted, inflammation certainly plays an important role in High Fat Diet-induced obesity and
cancer. Infiltrating inflammatory cells as well as systemic and local levels of pro-inflammatory mediators
provide in ideal micro-milieu for tumor development Anti-inflammatory strategies have been shown in many
animal models to delay or prevent the development of cancers and are widely considered intriguing
approaches for cancer prevention. Our preliminary studies have shown that a high fat, high calorie diet
(HFCD) in the presence of an inflammatory micro-environment substantially accelerates the development
and progression of pancreatic cancer precursor lesions in a genetically engineered animal model of
pancreatic cancer development Furthermore, our previous published studies have demonstrated that oral
administration of an anti-inflammatory drug delays the progression of pancreatic cancer precursor lesions in
the conditional Kras mouse model of pancreatic cancer development. In addition, dietary supplementation of
fish oil inhibited pancreatic cancer grov\rth in a xenograft mouse model, which was accompanied by reduced
levels of pro-inflammatory prostaglandin species. The overarching hypothesis of this Project is that a HFCD
promotes pancreatic cancer development and growth. This effect mediated and accelerated by the presence
of an inflammatory micro-environment. Targeting the inflammatory response may prevent pancreatic cancer
development promoted by the HFCD. To test our hypothesis the following three Specific Aims are proposed.
1) To determine the importance of pancreatic inflammation in HFCD-induced pancreatic cancer
development, 2) to characterize the importance of eicosanoids in HFCD-induced pancreatic cancer
development and investigate their mechanisms, and 3) to determine the efficacy of fish oil as an anti-
inflammatory strategy to reduce pancreatic cancer development. State-of-the-art genetically engineered
animal models will be utilized to test the hypotheses. Underlying mechanisms will be dissected in cell culture
systems that mimic the different stages of pancreatic cancer development.
RELEVANCE (See instructions):
We anticipate proving our hypothesis that strategies aimed at inhibiting the inflammatory component, e.g.
through fish oil, significantly delay or prevent the tumor-promoting effects of the high fat, high calohe diet.
Since today fish oil is widely used as a general health-promoting dietary supplement, our studies will provide
the scientific rationale for the use of fish oil to prevent pancreatic cancer and elucidate its mechanism. Our
results may also be transferable to other obesity-related cancer and even non-malignant chronic diseases.
大量证据表明,富含脂肪和卡路里的西式饮食是导致肥胖的关键因素
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guido Erwin Michael Eibl其他文献
Guido Erwin Michael Eibl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guido Erwin Michael Eibl', 18)}}的其他基金
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
慢性压力和肥胖在胰腺癌进展中的相互作用
- 批准号:
10409304 - 财政年份:2022
- 资助金额:
$ 20.69万 - 项目类别:
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
慢性压力和肥胖在胰腺癌进展中的相互作用
- 批准号:
10612088 - 财政年份:2022
- 资助金额:
$ 20.69万 - 项目类别:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
肥胖促进的胰腺癌的化学预防和机制
- 批准号:
10398844 - 财政年份:2020
- 资助金额:
$ 20.69万 - 项目类别:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
肥胖促进的胰腺癌的化学预防和机制
- 批准号:
10605224 - 财政年份:2020
- 资助金额:
$ 20.69万 - 项目类别:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
项目1:肥胖促进的胰腺癌中的脂肪组织炎症
- 批准号:
10398845 - 财政年份:2020
- 资助金额:
$ 20.69万 - 项目类别:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
项目1:肥胖促进的胰腺癌中的脂肪组织炎症
- 批准号:
10605225 - 财政年份:2020
- 资助金额:
$ 20.69万 - 项目类别:
Inflammatory processes In diet-Induced pancreatic cancer promotion
饮食诱发的胰腺癌促进中的炎症过程
- 批准号:
8561427 - 财政年份:2013
- 资助金额:
$ 20.69万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 20.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists